Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...

The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...

In January 2025, Aptose announced the initiation of the TUSCANY trial and dosing in the first cohort of newly-diagnosed AML patients with the lowest starting dose (40 mg) of TUS as part of the ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...

Particle Health, a leading intelligent data platform that aggregates and delivers actionable patient insights to healthcare companies, today announced it has completed certification for Surescripts ...

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

it is still unlikely that he would miss all of the refills of every medication in his medication profile. Furthermore, it can be assumed that the majority of the Vietnamese patients were required ...

The latest music icon to get the biopic treatment is none other than Bob Dylan, who is the focus of the 2024 new movie A Complete Unknown. Strapping on the guitar and filling the big shoes of Dylan is ...

A Complete Unknown could see Timothée Chalamet become the youngest-ever Best Actor winner after he picked up his second Oscars nomination for his portrayal of Bob Dylan. James Mangold's new movie ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

There were seven cases where patients taking the drug did complete a suicide. This is of course tragic. But these numbers need to be seen in the context of the number of people taking the drug.

Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for ...